ARTICLE | Clinical News
Jentadueto linagliptin/metformin regulatory update
June 4, 2012 7:00 AM UTC
EMA's CHMP issued a positive opinion recommending approval of an MAA from Boehringer for Jentadueto linagliptin/metformin to treat Type II diabetes. Boehringer and partner Eli Lilly market Jentadueto ...